Melanoma risk during immunomodulating treatment

Authors: Zheng, Yixuan James, Ho, Wilson, Sanlorenzo, Martina, Vujic, Igor, Daud, Adil, Algazi, Alain, Rappersberger, Klemens, Ortiz-Urda, Susana

Source: Melanoma research. 32(6):411-418

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172934080.0x000001&indx=1&recIds=ETOCvdc_100172934080.0x000001

Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome

Authors: Quaglino, Pietro, Fava, Paolo, Pileri, Alessandro, Grandi, Vieri, Sanlorenzo, Martina, Panasiti, Vincenzo, Guglielmo, Alba, Alberti-Violetti, Silvia, Novelli, Mauro, Astrua, Chiara, Rubatto, Marco, Tonella, Luca, Berti, Emilio, Pimpinelli, Nicola, Osella Abate, Simona, Fierro, Maria Teresa, Vermeer, Maarten, Scarisbrick, Julia J., Ribero, Simone

Source: In Journal of Investigative Dermatology March 2021 141(3):484-495

BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response

Authors: Ribero, Simone, Malavenda, Ottavia, Fava, Paolo, Astrua, Chiara, Marra, Elena, Osella-Abate, Simona, Sanlorenzo, Martina, Caliendo, Virginia, Fierro, Maria Teresa, Quaglino, Pietro

Source: Future oncology. 15(2):133-139

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186743011.0x000001&indx=1&recIds=ETOCvdc_100186743011.0x000001

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

Authors: Sanlorenzo, Martina, Vujic, Igor, Esteve-Puig, Rosaura, Lai, Kevin, Vujic, Marin, Lin, Kevin, Posch, Christian, Dimon, Michelle, Moy, Adrian, Zekhtser, Mitchell, Johnston, Katia, Gho, Deborah, Ho, Wilson, Gajjala, Abhinay, Oses Prieto, Juan, Burlingame, Alma, Daud, Adil, Rappersberger, Klemens, Ortiz-Urda, Susana

Source: Scientific reports. 8(1):1-9

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100171400562.0x000001&indx=1&recIds=ETOCvdc_100171400562.0x000001

The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis

Authors: Dapavo, Paolo, Vujic, Igor, Fierro, Maria Teresa, Quaglino, Pietro, Sanlorenzo, Martina

Source: In Journal of the American Academy of Dermatology October 2016 75(4):736-739

Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells

Authors: Posch, Christian, Sanlorenzo, Martina, Vujic, Igor, Oses-Prieto, Juan A., Cholewa, Brian D., Kim, Sarasa T., Ma, Jeffrey, Lai, Kevin, Zekhtser, Mitchell, Esteve-Puig, Rosaura, Green, Gary, Chand, Shreya, Burlingame, Alma L., Panzer-Grümayer, Renate, Rappersberger, Klemens, Ortiz-Urda, Susana

Source: In Journal of Investigative Dermatology October 2016 136(10):2041-2048

Searching for the Chokehold of NRAS Mutant Melanoma

Authors: Posch, Christian, Vujic, Igor, Monshi, Babak, Sanlorenzo, Martina, Weihsengruber, Felix, Rappersberger, Klemens, Ortiz-Urda, Susana

Source: In Journal of Investigative Dermatology July 2016 136(7):1330-1336

The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.

Authors: Feichtenschlager, Valentin, Chen, Linan, Zheng, Yixuan James, Ho, Wilson, Sanlorenzo, Martina, Vujic, Igor, Fewings, Eleanor, Lee, Albert, Chen, Christopher, Callanan, Ciara, Lin, Kevin, Qu, Tiange, Hohlova, Dasha, Vujic, Marin, Hwang, Yeonjoo, Lai, Kevin, Chen, Stephanie, Nguyen, Thuan, Muñoz, Denise P, Kohwi, Yoshinori

Source: Molecular Cancer; 2/22/2024, Vol. 23 Issue 1, p1-21, 21p

Subject Terms: LINCRNA, CANCER cells, MICROPHTHALMIA-associated transcription factor, CELL survival, IPILIMUMAB, MELANOMA, PROTEIN stability

Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma

Authors: Posch, Christian ^*, Cholewa, Brian D., Vujic, Igor, Sanlorenzo, Martina, Ma, Jeffrey, Kim, Sarasa T., Kleffel, Sonja, Schatton, Tobias, Rappersberger, Klemens, Gutteridge, Rosie, Ahmad, Nihal, Ortiz-Urda, Susana

Source: In Journal of Investigative Dermatology October 2015 135(10):2475-2483

Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies

Authors: Kwong, Andrew, Sanlorenzo, Martina, Rappersberger, Klemens, Vujic, Igor

Source: Wiener medizinische Wochenschrift. 169(13-14):314-322

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100118571027.0x000001&indx=1&recIds=ETOCvdc_100118571027.0x000001

Role of interferon in melanoma: old hopes and new perspectives

Authors: Sanlorenzo, Martina, Vujic, Igor, Carnevale-Schianca, Fabrizio, Quaglino, Pietro, Gammaitoni, Loretta, Fierro, Maria Teresa, Aglietta, Massimo, Sangiolo, Dario

Source: Expert opinion on biological therapy. 17(4):475-483

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100106499772.0x000001&indx=1&recIds=ETOCvdc_100106499772.0x000001

Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma

Authors: Sanlorenzo, Martina, Choudhry, Aditi, Vujic, Igor, Posch, Christian, Chong, Kim, Johnston, Katia, Meier, Melissa, Osella-Abate, Simona, Quaglino, Pietro, Daud, Adil, Algazi, Alain, Rappersberger, Klemens, Ortiz-Urda, Susana

Source: In Journal of the American Academy of Dermatology December 2014 71(6):1102-1109

New insights in melanoma biomarkers: long-noncoding RNAs

Authors: Moreno-Traspas, Ricardo, Vujic, Igor, Sanlorenzo, Martina, Ortiz-Urda, Susana

Source: Melanoma management. 3(3):195-205

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139386698.0x000001&indx=1&recIds=ETOCvdc_100139386698.0x000001

Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives

Authors: Sanlorenzo, Martina, Vujic, Igor, Moy, Adrian, Quaglino, Pietro, Fierro, Maria Teresa, Gammaitoni, Loretta, Carnevale-Schianca, Fabrizio, Aglietta, Massimo, Sangiolo, Dario

Source: Expert opinion on biological therapy. 15(10):1491-1500

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100106457644.0x000001&indx=1&recIds=ETOCvdc_100106457644.0x000001

Prognostic differences across sexes in melanoma patients: what has changed from the past?

Authors: Sanlorenzo, Martina, Ribero, Simone, Osella-Abate, Simona, Zugna, Daniela, Marenco, Federica, Macripò, Giuseppe, Fierro, Maria T., Bernengo, Maria G., Quaglino, Pietro

Source: Melanoma research. 24(6):568-576

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100030241373.0x000001&indx=1&recIds=ETOCvdc_100030241373.0x000001

Melanoma immunotherapy

Authors: Sanlorenzo, Martina, Vujic, Igor, Posch, Christian, Dajee, Akshay, Yen, Adam, Kim, Sarasa, Ashworth, Michelle, Rosenblum, Michael D, Algazi, Alain, Osella-Abate, Simona, Quaglino, Pietro, Daud, Adil, Ortiz-Urda, Susanna

Source: Cancer biology & therapy. 15(6):665-674

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100050659947.0x000001&indx=1&recIds=ETOCvdc_100050659947.0x000001

Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives.

Authors: Roccuzzo, Gabriele, Giordano, Silvia, Fava, Paolo, Pileri, Alessandro, Guglielmo, Alba, Tonella, Luca, Sanlorenzo, Martina, Ribero, Simone, Fierro, Maria Teresa, Quaglino, Pietro

Source: Frontiers in Oncology; 8/16/2021, Vol. 11, p1-10, 10p

Subject Terms: IMMUNE checkpoint inhibitors, IMMUNE checkpoint proteins, LYMPHOMAS, MYCOSIS fungoides, SURVIVAL rate

Company/Entity: CHECK Point Software Technologies Ltd.

A meta-analysis of melanoma risk in industrial workers.

Authors: Vujic, Igor, Gandini, Sara, Stanganelli, Ignazio, Fierro, Maria T., Rappersberger, Klemens, Sibilia, Maria, Tosti, Giulio, Ferrucci, Pier F., Caini, Saverio, De Felici, Maria B., Pagliarello, Calogero, Quaglino, Pietro, Sanlorenzo, Martina

Source: Melanoma Research; Jun2020, Vol. 30 Issue 3, p286-296, 11p

This result is not displayed to guests.
Login for full access.

Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies.

Alternate Title: Update zur Behandlung fortgeschrittener Melanome: zielgerichtete Therapie mit kleinmolekularen Hemmstoffen, Immuntherapie und zukünftige Kombinationstherapien. (German)

Authors: Kwong, Andrew, Sanlorenzo, Martina, Rappersberger, Klemens, Vujic, Igor

Source: Wiener Medizinische Wochenschrift; Oct2019, Vol. 169 Issue 13/14, p314-322, 9p